```html

Xanthoma (Fatty Skin Deposits)

What is Xanthoma (fatty skin deposits)?

Xanthomas are yellow‑orange, well‑defined skin lesions that result from the buildup of cholesterol‑rich lipid particles within cells of the skin and tendons. The word “xanthoma” comes from the Greek *xanthos*, meaning “yellow.” Although they look benign, xanthomas are often a visible clue that a deeper metabolic or lipid disorder is present. They can appear anywhere on the body but are most common on the elbows, knees, hands, feet, and around the eyes (called xanthelasma).

These deposits are not cancerous, but they signal that the body’s handling of fats and cholesterol is abnormal. Because the underlying cause can be serious—ranging from inherited lipid disorders to liver disease—recognizing xanthomas early can prompt timely evaluation and treatment, reducing the risk of cardiovascular events.

Common Causes

Below are the most frequent conditions that lead to xanthoma formation. Many of them are inter‑related, so a thorough work‑up is essential.

• Familial hypercholesterolemia (FH) – a genetic defect in LDL‑receptor function that causes very high LDL‑cholesterol from birth.
• Familial combined hyperlipidemia – elevated LDL, VLDL, and triglycerides, often seen in adolescents and young adults.
• Type IIa hyperlipoproteinemia – isolated high LDL, associated with premature atherosclerosis.
• Type IIb hyperlipoproteinemia – high LDL + VLDL, leading to mixed xanthomas (tendon, eruptive).
• Type III dysbetalipoproteinemia – impaired clearance of remnant particles; classically produces palmar xanthomas.
• Primary biliary cholangitis / cholestatic liver disease – impaired bile excretion raises serum cholesterol, causing eruptive or tuberous xanthomas.
• Diabetes mellitus (especially poorly controlled) – high triglycerides can trigger eruptive xanthomas.
• Nephrotic syndrome – massive protein loss leads to hepatic over‑production of lipoproteins.
• Hypothyroidism – reduces LDL receptor activity, raising LDL levels.
• Medication‑induced – drugs such as cyclosporine, efavirenz, and high‑dose oral retinoids can raise lipid levels.

Associated Symptoms

While the xanthomas themselves are usually painless, they often coexist with other signs of lipid or systemic disease:

• Chest pain or angina – indicating coronary artery disease.
• Claudication (leg pain with walking) – peripheral arterial disease.
• Fatigue, shortness of breath – possible heart failure from atherosclerosis.
• Darkened or thickened skin patches (palmar xanthomas) – suggest type III dysbetalipoproteinemia.
• Pruritus or jaundice – may point to cholestatic liver disease.
• Weight loss, edema, or foamy urine – signs of nephrotic syndrome.
• Changes in thyroid function (cold intolerance, constipation) – hint at hypothyroidism.

When to See a Doctor

Because xanthomas can be an early warning of serious cardiovascular or metabolic disease, seek medical attention if you notice any of the following:

• New yellowish bumps that appear suddenly or increase in size.
• Multiple or widespread xanthomas, especially on tendons, palms, or around the eyes.
• Any family history of early heart attacks, strokes, or high cholesterol.
• Accompanying symptoms such as chest pain, shortness of breath, or leg swelling.
• History of liver, kidney, or thyroid disease that is not well controlled.
• Sudden change in skin texture (hardening, ulceration) around a xanthoma.

Diagnosis

Diagnosis relies on a combination of visual assessment, laboratory testing, and sometimes imaging or biopsy.

1. Physical Examination

The clinician will document the size, number, location, and type of xanthoma (e.g., tendinous, eruptive, tuberous, or xanthelasma).

2. Blood Tests

• Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Apolipoprotein B and E levels – useful for type III dysbetalipoproteinemia.
• Liver function tests (ALT, AST, ALP, GGT, bilirubin) – evaluate cholestasis.
• Renal panel & urine protein – screen for nephrotic syndrome.
• Thyroid‑stimulating hormone (TSH) – detect hypothyroidism.

3. Imaging

• Ultrasound or carotid Doppler – assess for atherosclerotic plaque.
• Coronary calcium scoring CT – optional for high‑risk patients.

4. Skin Biopsy (rarely needed)

If the diagnosis is uncertain, a small punch biopsy can confirm the presence of lipid‑laden macrophages (foam cells) within the dermis.

Treatment Options

Therapy focuses on two goals: (1) address the underlying metabolic disorder, and (2) improve the cosmetic appearance of the lesions if desired.

1. Lifestyle Modification

• Heart‑healthy diet – emphasize soluble fiber, omega‑3 fatty acids, plant sterols, and limit saturated/trans fats.
• Physical activity – at least 150 minutes of moderate aerobic exercise per week.
• Weight management – a 5‑10 % weight loss can substantially lower LDL and triglycerides.
• Smoking cessation – eliminates a major cardiovascular risk factor.

2. Pharmacologic Therapy

• Statins (e.g., atorvastatin, rosuvastatin) – first‑line for most hypercholesterolemia; can reduce xanthoma size over months.
• Ezetimibe – added when LDL goals are not met with statins alone.
• PCSK9 inhibitors (evolocumab, alirocumab) – powerful LDL‑lowering agents for familial hypercholesterolemia or statin‑intolerant patients.
• Fibrates (gemfibrozil, fenofibrate) – effective for high triglycerides and eruptive xanthomas.
• Niacin – raises HDL‑C and lowers triglycerides, but use is limited by side‑effects.
• Bile‑acid sequestrants (cholestyramine) – useful adjuncts, especially in cholestatic disease.
• Levothyroxine – treats hypothyroidism, which in turn improves lipid profile.
• Immunosuppressants or cholestasis‑targeted agents – for liver disease‑related xanthomas (e.g., ursodeoxycholic acid).

3. Cosmetic / Procedural Options

• Laser therapy (e.g., Q‑switched Nd:YAG) – can fade superficial xanthelasma.
• Radiofrequency or cryotherapy – occasionally used for isolated, bothersome lesions.
• Surgical excision – reserved for large, nodular xanthomas causing functional impairment.
• Topical retinoids – limited evidence; may modestly improve texture.

Importantly, cosmetic removal does **not** replace the need for systemic lipid management; lesions often recur if the underlying cause persists.

Prevention Tips

While some genetic lipid disorders cannot be prevented, many risk factors are modifiable:

• Follow a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and olive oil.
• Keep total cholesterol < 200 mg/dL and LDL‑C < 100 mg/dL (or lower if high risk).
• Maintain triglycerides < 150 mg/dL through diet and regular exercise.
• Schedule routine lipid panels at least every 5 years for adults; earlier if you have a family history.
• Control blood pressure and blood glucose – both influence lipid metabolism.
• Avoid excessive alcohol, which can raise triglycerides.
• Stay up‑to‑date with vaccinations (e.g., hepatitis B) that protect liver health.
• Discuss any medication that may affect lipids with your pharmacist or physician.

Emergency Warning Signs

Key Take‑aways

Xanthomas are more than skin‑deep yellow bumps; they are visual cues that lipid metabolism may be out of balance. Prompt evaluation, targeted lipid‑lowering therapy, and healthy lifestyle habits can not only improve the appearance of the lesions but, more importantly, dramatically lower the risk of heart attack, stroke, and other life‑threatening complications.

For detailed guidance tailored to your situation, consult a primary‑care physician, endocrinologist, or lipid specialist. Reliable sources for further reading include the Mayo Clinic, American Heart Association, National Institutes of Health, and the Cleveland Clinic.

```